等待开盘 02-06 09:30:00 美东时间
-6.190
-4.68%
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
Q2业绩全面碾压预期!SanDisk涨近143%“带飞”存储板块,美光、西数涨超45%;电力公司Bloom Energy涨74.2%,SOFC为AI数据中心供电商业闭环彻底打通>>
01-31 10:30
These 10 stocks posted best or worst months ever in January. Earnings surprises, AI disruption and sector rotation explain why.
01-31 03:51
今日重点评级关注:瑞穗:维持Syndax制药"跑赢大市"评级,目标价从410美元升至600美元;HC Wainwright & Co.:维持60 Degrees Pharmaceuticals, Inc."买入"评级,目标价从6美元升至24美元
01-28 10:59
Ratings for Guidewire Software (NYSE:GWRE) were provided by 10 analysts in the ...
01-27 21:01
BTIG analyst Allan Verkhovski assumes Guidewire Software (NYSE:GWRE) with a Buy rating and announces Price Target of $250.
01-27 20:09
NFU Mutual Selects Guidewire Cloud Platform for InsuranceSuite Migration Guidewire Software Inc. announced that NFU Mutual will migrate its on-premises deployment of Guidewire InsuranceSuite to the Guidewire Cloud Platform. This move is part of an ongoing partnership between the two companies, with
01-27 15:31
Guidewire CEO Michael George Rosenbaum Reports Sale of Common Shares Michael George Rosenbaum, Chief Executive Officer of Guidewire Software Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by P
01-23 01:30
Regencell led last week's large-cap losers as Figma, Atlassian and Trip.com slid on downgrades, probes and broader tech weakness.
01-19 01:31
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22